 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
What's New at The BodyHIV/AIDS News You Can UseSeptember 26, 2002 | ||||||||||
Next-Day Coverage of the 2002 Lipodystrophy ConferenceClick below to read the latest news and research coming out of the 4th annual International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (ADRL 2002), currently underway in San Diego. Our expert on the scene, Pablo Tebas, M.D., brings you all the major developments.Plus, don't forget: This weekend, The Body begins its next-day coverage of ICAAC 2002 -- the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy! Food-Poisoning Warning in PennsylvaniaThe U.S. Food and Drug Administration and the Food Safety Inspection Service are advising the public -- particularly people with weakened immune systems -- of a recent increase in cases of listeria in Pennsylvania and possibly in adjoining states. The warning advises at-risk people not to eat hot dogs, lunch meats, soft cheeses, smoked seafood or many other common foods.At Last, a New Hepatitis B DrugThe U.S. Food and Drug Administration announced the approval of Hepsera (adefovir dipivoxil) tablets for the treatment of chronic hepatitis B.Dangerous Interactions: HAART and Party DrugsPeople with HIV who use protease inhibitors (such as Viracept and Kaletra) or NNRTIs (such as 3TC and d4T) can develop life-threatening complications when they also use party drugs such as Ecstasy.Increasingly, People With HIV Are WomenAlthough in the U.S. the stereotype persists that AIDS is a gay disease, 47 percent of the 34.7 million adults living with HIV throughout the world are women. Read more on HIV in women from STEP Perspective.Alarmingly Few Gay, Bisexual Men Have Hepatitis VaccinationsOver the summer, the Gay and Lesbian Medical Association surveyed 4,152 men at more than two dozen Pride events around the country. Only 38 percent of respondents on a national basis reported receiving any doses of a vaccine against hepatitis A, and 42 percent said they'd been vaccinated against hepatitis B.Complacency on HIV May Prove Deadly"Because AIDS isn't on the front page anymore, too many people think the disease is no longer an issue. And here's the horrible irony: Times are tougher than ever for those in our community living with HIV and AIDS." Executive director of Lifelong AIDS Alliance, Chuck Kuehn, writes about the epidemic in Seattle.Tamoxifen Used for Male Breast EnlargementAnecdotal reports suggest that the drug tamoxifen (Novaldex, Tamofen) is becoming a common option for the treatment of male breast enlargement associated with the use of HAART.Diarrhea: How to Ease Your SymptomsDiarrhea again? Here are some treatment options for medication-induced diarrhea from Positively Aware.Despite Hep C and HIV, She Is in ChargeSylvia O'Shaughnessy talks frankly about her experience living with HIV and hepatitis C, in Positively Aware.When First Treated for HIV, Latinos in Worse ShapeA recent study indicates that patients from minority populations -- especially Latinos -- appear in doctor's offices with more advanced HIV disease when compared with whites. Latinos are also significantly more likely to have a major opportunistic infection on their first doctor's visit. Once they begin care, however, increases in CD4 T-cell counts and decreases in viral loads were no different for Latinos than for whites.Advice for Exercise BuffsExercise is an important part of a healthy life for everyone -- especially people living with HIV. There are lots of tips to keep in mind when exercising, though, such as being sure to eat the right foods and to warm up both before and after you exercise. Read this helpful guide from Positively Aware.The Key to Adherence: Directly Observed Therapy?What is "directly observed therapy" (DOT), and what does it have to do with HAART? Dr. Lara Strick explains the latest research on DOT, which has the potential to greatly improve a person's adherence to meds.Web HighlightsA Selection of the Top HIV/AIDS Stories From Across the Internet:AIDS Epidemic Sweeps East Mediterranean AIDS Confab Focus: Transgenders Giving AIDS the Red Light Cost-Effectiveness of HIV Prevention in Developing Countries Mitochondrial Toxicity in HAART | ||||||||||